NCT04239846View on ClinicalTrials.gov

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

May 12, 2021

Study Completion Date

May 26, 2021

Conditions
EGFR Inhibitor-Induced Skin Rash
Interventions
DRUG

AC-701 Topical Gel 0.3%

AC-701 Topical Gel 0.3%, BID

OTHER

Placebo Gel

Placebo Gel, BID

Trial Locations (2)

Unknown

Taipei Veterans General Hospital, Taipei

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

TWi Biotechnology, Inc.

INDUSTRY

NCT04239846 - Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy | Biotech Hunter | Biotech Hunter